Loss of 17p, Mutation of the p53 Gene, and Overexpression of p53 Protein in Esophageal Squamous Cell Carcinomas

Cancer Research

Volumn 53, Issue 4, 1993, Pages 846-850

  Yandell, David W ^b   Ikenaga, Mituo ^a   Shimada, Yutaka ^a   Ishizaki, Kanji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CHROMOSOME 17P; CLINICAL ARTICLE; DNA POLYMORPHISM; ESOPHAGUS CARCINOMA; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN P53; SUPPORT, NON-U.S. GOV'T;

EID: 0027513248     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cavcncc, W. K. Dryja, T. P. Phillips, R. A. Benedict, W. F. Godbout, R. Gallic B. L. Murphree, A. L. Strong, L. C. and White, R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (Lond.). 305:779-784,1983.
2. McBride, O. W. Merry, D. and Givol, D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17pl3). Proc. Natl. Acad. Sci. USA, 83: 130-134, 1986.
3. Fearon, E. R. Hamilton, S. R. and Vogelstein, B. Clonal analysis of human colorectal tumors. Science (Washington DC), 238: 193-197, 1987.
4. Yokota, J. Wada, M. Shimosato, Y. Terada, M. and Sugimura, T. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 84: 9252-9256, 1987.
5. Mackay, J. Steel, C. M. Elder, P. A. Forrest, A. P. M. and Evans, H. J. Allele loss on short arm of chromosome 17 in breast cancers. Lancet, 2: 1384-1385, 1988.
6. Toguchida, J. Ishizaki, K. Nakamura, Y. Sasaki, M. S. Ikenaga, M. Kato, M, Sugimoto, M. Kotoura, Y, and Yamamuro, T. Assignment of common allele loss in osteosarcoma to the subregion 17pl3. Cancer Res. 49: 6247-6251, 1989.
7. Nigro, J. M. Baker, S. J. Preisinger, A. C. Jessup, J. M. Hostetter, R. Cleary, K. Bigner, S. H. Davidson, N. Baylin, S. Devilee, P. Glover, T. Collins, F. S. Weston, A. Modali, R. Harris, C. C. and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
8. Levine, A. J. Momand, J. and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 557: 453-456, 1991.
9. Hollstein, M. Sidransky, D. Vogelstein, B. and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
10. Knudson, A. G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA. 68: 820-823, 1971.
11. Baker, S. J. Preisinger, A. C. Jessup, J. M. Paraskeva, C. Markowitz, S. Willson, K. V. Hamilton, S. and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50: 7717-7722, 1990.
12. Takahashi, T. Nau, M. M. Chiba, I. Birrer, M. J. Rosenberg, R. K. Vinocour, M. Levitt, M. Pass, H. Gazdar, A. F. and Minna, J. D. p53 a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
13. Fujimori, M. Tokino, T. Hino, O. Kitagawa, T. Imamura, T, Okamoto, E. Mitsunobu, M. Ishikawa, T. Nakagama, H. Harada, H. Yagura, M. Matsubara, K. and Nakamura, Y Allelotype study of primary Hepatocellular carcinoma. Cancer Res. 51: 89-93. 1991.
14. Sato, T. Tanigami, A. Yamakawa, K. Akiyama, F. Kasumi, F, Sakamoto G. and Nakamura, Y Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res. 50: 7184-7189, 1990.
15. Oren, M. Maltzman, W. and Levine, A. J. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol. 1: 101-110, 1981.
16. Oren, M. The p53 cellular tumor antigen: gene structure, expression and protein. Biochim. Biophys. Acta, 823: 67-68, 1985.
17. Cunningham, J. Lust, J. A. Schaid, D. J. Bren, G. D. Carpenter, H. A. Rizza, E. Kovach, J. S. and Thibodeau, S. N. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res. 52: 1974-1980, 1992.
18. Thompson, A. M. Anderson, T. J. Condie, A. Prosser, J. Chetty, U. Carter, D. C. Evans, H. J. and Steel, C. M. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int. J. Cancer, 50: 528-532, 1992.
19. Wagata, T. Ishizaki, K. Imamura, M. Shimada, Y. Ikenaga, M. and Tobe, T. Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res. 57:2113-2117. 1991.
20. Hollstein, M. C. Metcalf, R. A. Welsh, J. A. Montesano, R. and Harris, C. C. Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958-9961, 1990.
21. Hollstein, M. C. Peri, L. Mandard, A. M. Welsh, J. A. Montesano, R. Metcalf, R. A. Bak, M. and Harris, C. C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res. 57: 4102-4106, 1991.
22. Bennett, W. P. Hollstein, M. C. He, A. Zhu, S. M. Resau, J. H. Trump, B. F. Metcalf, R. A. Welsh, J. A. Midgley, C. Lane, D. P. and Harris, C. C. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene, 6: 1779-1784, 1991.
23. Buchman, V. L. Chumakov, P. M. Ninkina, N. N. Samarina, O. P. and Georgiev, G. P. A vaRIation in the structure of the protein-coding region of the human p53 gene. Gene, 70: 245-252, 1989.
24. Calle-Martin, O. de la Fabregat, V. Romero, M. Soler, J. Vives, J. and Yague, J. AccII polymorphism of the p53. Nucleic Acids Res. 18: 4963, 1990.
25. Orita, M. Suzuki, Y. Sekiya, T. and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
26. Toguchida, J. Yamaguchi, T. Dayton, S. H. Beauchamp, R. L. Herrera, G. E. Ishizaki, K. Yamamuro, T. Meyers, P. A. Little, J. B. Sasaki, M. S. Weichselbaum, R. R. and Yandell, D. W. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N. Engl. J. Med. 326: 1301-1308, 1992.
27. Soussi, T. De Fromentel, C. C. and May, P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5: 945-952, 1990.
28. Sved, J. and Bird, A. The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc. Natl. Acad. Sci. USA, 87: 4692-4696, 1990.
29. Fults, D. Brockmeyer, D. Tullous, M. W. Pedone, C. A. and Cawthon, R. M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 52: 674-679, 1992.
30. Sameshima, Y. Matsuno, Y, Hirohashi, S. Shimosato, Y. Mizoguchi, H. Sugimura, T. Terada, M. and Yokota, J. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene, 7: 451-457, 1992.
31. Eliyahu, D. Goldfinger, N. Pinhasi-kimhi, O. Shaulsky, G. Skumik, Y. Arai, N. Rotter, V. and Oren, M. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene, 3: 313-321, 1988.
32. Kraiss, S. Quaiser, A. Oren, M. and Montenarh, M. Oligomerization of oncoprotein p53. J. Virol. 62: 4737-4744, 1988.
33. Milner, J. Medcalf, E. A. and Cook, A. C. Tumor suppressor p53: analysis of wild type and mutant p53 complexes. Mol. Cell. Biol. 77: 12-19, 1991.
34. Takahashi, T. D'Amico, D. Chiba, I. Buchhagen, D. L. and Minna, J. D. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J. Clin. Invest. 86: 363-369, 1990.
35. Chiba, I. Takahashi, T. Nau, M. M. D'Amico, D. Curiel, D. T. Mitsudomi, T. Buchhagen, D. L. Carbone, D. Piantadosi, S. Koga, H. Reissman, P. T. Slamon, D. J. Holmes, E. C. and Minna, J. D. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
36. Suzuki, H. Takahashi, T. Kuroishi, T, Suyama, M. Ariyoshi, Y. Takahashi, T. and Ueda, R. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res. 52: 734-736, 1992.
37. Hsu, I. C. Metcalf, R. A. Sun, T. Welsh, J. A. Wang, N. J. and Harris C. C. Mutational hot spot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
38. Bressac, B. Kew, M. Wands, J. and Ozturk, M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
39. Day, N. E. and Munoz, N. Esophagus. In: D. Schottenfeld and J. F. Fraumeni (eds.), Cancer Epidemiology and Prevention, pp. 596-623. Philadelphia: W. B. Saunders, Co. 1982.
40. Yu, M. C. Garabrant, D. H. Peters, J. M. and Mack, T. M. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res. 48: 3843-3848, 1988.